ACH CEO Amanda Pears Kelly spoke with Bloomberg Government about the growing strain on community health centers amid the ongoing federal shutdown. In the interview with reporter Erin Durkin, Pears Kelly noted that currently CHCs can access short-term funding but face greater unknowns as the shutdown persists. She stated, “What that looks like as this […]
Advocates for Community Health issued the following statement in response to the Federal Government shutdown, in effect today: Advocates for Community Health (ACH) warns that a federal government shutdown could be devastating for community health centers and the nearly 34 million patients who depend on them if a resolution is not reached quickly. Already facing staggering […]
Community Health Centers (CHCs), also called Federally Qualified Health Centers (FQHCs), may be our nation’s best health policy experiment, delivering a bold return on investment in the sixty years since their inception. Every $1 invested in primary care returns $13 in saved downstream costs. From urban areas to rural communities, CHCs play a crucial role […]
In an article from the 340B Report covering the reintroduction of the 340B ACCESS Act, ACH shared that the organization “is broadly supportive of congressional efforts to reform the 340B program, including requiring more transparency and accountability as we advocate to ensure that 340B can remain a viable component of the vital work health centers […]
Advocates for Community Health has issued the following statement in response to the Congressional Budget Office’s (CBO) report released September 9th: Advocates for Community Health welcomes new research and data on the 340B program that help policymakers understand the vital role the program plays to health centers. While the CBO report failed to acknowledge it […]
The 340B drug pricing program has long been a critical tool for community health centers, enabling them to stretch scarce resources and deliver affordable care to millions of patients—often in America’s rural and underserved communities. But today, this key healthcare funding lifeline is facing new challenges that could threaten its future. In our latest episode […]
As HRSA considers whether to permit changes to the 340B Discount Drug Program, namely shifting to a rebate-based model – safety net hospitals and community health leaders are sounding the alarm. Under debate is whether drugs are sold at full price with rebates issued after purchase, rather than the traditional upfront discount many CHCs rely […]
The Health and Human Services Department is eyeing a major shakeup with big implications for safety-net providers, reports Modern Healthcare. One potential benefit would be having a single agency managing several prescription drug programs, said Elizabeth Lee, a policy advisor at Advocates for Community Health, which represents community health centers. CMS handles Medicare outpatient drug price […]
Ensuring that the 340B Drug Pricing Program Enables Health Centers to Meet Their Mission By allowing the purchase of drugs at a discounted price, the 340B Drug Pricing Program enables health centers and other covered entities to funnel the resulting savings into serving more patients with highly complex clinical and social needs than they otherwise […]
The 340B Drug Pricing Program has long served as a vital resource for Community Health Centers (CHCs), allowing them to stretch limited federal dollars and provide care to their communities, particularly rural and underserved areas. Under 340B, CHCs purchase medications at a discount, and reinvest those savings into expanded services, staff, and access points for […]